Disposals impact Bupa’s first half

Bupa reported today that underlying profit fell by 13% in the first half of 2018 as care home disposals and the divestment of its...

The London Clinic invests in ‘multi-million-pound’ scanner 

 The London Clinic has acquired a high-strength diagnostic imaging scanner which will be used to help treat patients with cancer and conditions involving the...

APRIL UK in new PMI agreement with AXA PPP healthcare

AXA PPP healthcare is to offer APRIL UK’s health insurance customers continuation of their cover following APRIL UK’s decision last week to exit the...

Cygnet acquires Danshell

Cygnet Health Care, a UK subsidiary of hospital management company Universal Health Services, has acquired the Danshell Group for an undisclosed sum. Adding 25 facilities...

Nuffield to open PPU at St Bartholomew’s

Nuffield Health is to open a £60m 48-bed private patient unit on site at St Bartholomew’s, London’s oldest hospital, following approval from the City...

PHIN delays publication of consultant measures

The Private Healthcare Information Network (PHIN) has extended its planned deadline for the publication of private consultant clinical outcomes data. Performance information for some 1,000...

BDC exits Acteon

Bridgepoint Development Capital (BDC) is planning to sell its majority stake in French medtech company Acteon Group to Dentressangle, a French family investment holding...

Senior appointments at the Huntercombe Group

The Huntercombe Group has made two senior appointments to oversee improvements in quality and governance across its mental health and brain injury services. Philip King...

Unlocking the potential of In Vitro Diagnostics

In Vitro Diagnostics is gaining the attention of pharma companies and health systems across the globe as new technology paves the way for early...

Harley Street Clinic invests in brain cancer technology in UK first  

HCA’s Harley Street Clinic has acquired a medical device designed to treat patients with aggressive and complex brain tumours previously considered untreatable. Clinical trials for...